Purpose There is a potential risk that lobular carcinoma in situ (LCIS) on preoperative biopsy
might be diagnosed as ductal carcinoma in situ (DCIS) or invasive carcinoma in the final …

Background: The risk of developing invasive breast cancer after finding lobular carcinoma in
situ (LCIS) is controversially reported in the literature. The surgeon who finds LCIS …

The primary aim of this study was to determine the upgrade rates of variant lobular
carcinoma in situ (V-LCIS, ie, combined florid [F-LCIS] and pleomorphic [P-LCIS]) compared …

Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of discohesive cells arising in
the terminal duct lobular unit. LCIS was initially described as a marker of bilateral increased …

Background Lobular carcinoma in situ (LCIS) is considered a risk factor—not a precursor—
for both invasive lobular and ductal carcinoma. Florid LCIS (F-LCIS) is an architectural …

OBJECTIVE. The objective of our study was to show the importance of surgical excision after
the diagnosis of lobular carcinoma in situ (LCIS) based on needle core biopsy. MATERIALS …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

Aim To determine if the outcomes of patients with ILC co-occurring with LCIS are similar to
pure ILC and if the presence of LCIS is a prognostic factor for ILC. Methods In an …

Many historical evolutions of concepts have emerged regarding lobular neoplasia (LN)
since 1865, when Cornil first described this entity as" intraepithelial breast carcinoma in …

Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …